# E-cadherin and Integrin Alpha v Beta 1 in Vitiligo

> **NCT05287776** · NA · UNKNOWN · sponsor: **Kasr El Aini Hospital** · enrollment: 15 (estimated)

## Conditions studied

- Vitiligo

## Interventions

- **DEVICE:** Narrow band UVB

## Key facts

- **NCT ID:** NCT05287776
- **Lead sponsor:** Kasr El Aini Hospital
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2019-06-01
- **Primary completion:** 2022-05-01
- **Final completion:** 2022-12-01
- **Target enrollment:** 15 (ESTIMATED)
- **Last updated:** 2022-03-18


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05287776

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05287776, "E-cadherin and Integrin Alpha v Beta 1 in Vitiligo". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT05287776. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*